(1)
Design, Synthesis, and In-Silico Evaluation of Benzyl Oxybenzoate Derivatives As Dual HDAC Inhibitors for Cancer and CNS Disorders. AJPS 2026, 25 (5), 917-930. https://doi.org/10.32947/ajps.v25i5.1307.